Toxicokinetics, a pivotal facet of pharmacology, intricately scrutinizes the absorption, distribution, metabolism, and excretion (ADME) processes of toxic substances within the biological system. Commencing with absorption, these pharmacologically relevant toxins ingress into the bloodstream, undergoing subsequent distribution to various tissues. The crux of metabolism follows, where toxic compounds undergo transformation into either less deleterious forms or potentially more pharmacologically active metabolites. Sophisticated methodologies, including pharmacokinetic modeling and cutting-edge analytical techniques, are deployed by researchers to unravel the intricate dynamics inherent in toxicokinetics. These discernments play a pivotal role in shaping efficacious detoxification strategies and informing therapeutic interventions, thereby fostering a comprehensive approach to the pharmaceutical management of toxic exposures. Such advancements empower the pharmaceutical industry to develop innovative solutions for mitigating the impact of toxic substances, ultimately promoting the well-being of individuals and communities.
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Development of novel drug delivery pathways enabled by perillyl alcohol (NEO100), A monoterpene with multifaceted biomedical applications
Axel H Schonthal, University of Southern California, United States
Title : From marker to mechanism: Ligand discovery enables functional analysis of OR51E1, an ectopic olfactory receptor, in prostate cancer
Vladlen Slepak, University of Miami, United States
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model based on design-inspired biotech- & biopharma-driven applications to secure the human healthcare and biosafety
Sergey Suchkov, N D Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : R&D consultancy at the medicines discovery catapult: De-risking drug discovery for innovators
Adriana Gambardella, Medicine Discovery Catapult, United Kingdom
Title : Biocompatible synthesis of non crystalline iron oxide nanoparticles with stable colloidal properties
Lan Wang, Paretor LLC, United States
Title : Hydrogen sulfide in sepsis: From bench to bedside
Madhav Bhatia, University of Otago, New Zealand
Title : Biocompatibility and subcutaneous host response to silk fibroin–chitosan composite plugs: Progress toward biodegradable implant materials
Luis Jesus Villarreal Gomez, Universidad Autónoma de Baja California, Mexico